Cialis vs Viagra Head-to-Head Efficacy: Which PDE5 Inhibitor Actually Works Better?

What Are Cialis and Viagra, and How Do They Work?

Tadalafil (Cialis) and sildenafil (Viagra) both block phosphodiesterase type 5 (PDE5), an enzyme that degrades cyclic GMP (cGMP) in penile smooth muscle. Blocking PDE5 keeps cGMP elevated, relaxes smooth muscle, and allows blood to fill the corpus cavernosum during sexual stimulation. Neither drug produces an erection without arousal. Their pharmacokinetics diverge sharply after that shared mechanism, and those differences drive most of the prescribing decisions clinicians face today.

Sildenafil: The Original PDE5 Inhibitor

Sildenafil was the first oral PDE5 inhibitor approved by the FDA, in March 1998. The key registration trial by Goldstein et al., published in the New England Journal of Medicine, enrolled 532 men with erectile dysfunction across a 24-week double-blind protocol. The 100 mg dose produced successful intercourse in 69% of attempts versus 22% on placebo 1. The IIEF (International Index of Erectile Function) erectile-function domain score improved by 7.0 points on 100 mg versus 1.0 point on placebo, a difference that remained statistically significant at P<0.001 1.

Sildenafil reaches peak plasma concentration (Tmax) in approximately 60 minutes under fasted conditions, though a high-fat meal can delay Tmax by up to 60 minutes and reduce Cmax by 29% according to the FDA-approved prescribing information 2. Its half-life is roughly 4 hours, which limits the window of responsiveness to about 4 to 6 hours post-dose.

Tadalafil: The "Weekend Pill" and Daily Option

Tadalafil entered the US market in November 2003. Beyond on-demand use, it is the only PDE5 inhibitor in this class approved in the United States for both ED and benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS), at a 5 mg once-daily dose 3. Its half-life is 17.5 hours, producing the characteristic 36-hour window often cited in prescribing discussions.

Brock et al. (2002), in a landmark comparison published in the Journal of Urology, confirmed that tadalafil's longer half-life translated into a broader activity window versus sildenafil without a meaningful difference in on-demand efficacy rates 4. The study also examined patient preference patterns, finding that men who reported spontaneous sexual activity preferred the extended window tadalafil provided.

Head-to-Head Efficacy: What the Data Actually Show

No single large randomized trial has directly compared tadalafil and sildenafil with the statistical power needed to declare one agent superior for erectile function endpoints. What exists are indirect comparisons, crossover preference studies, and meta-analyses, all of which point to roughly equivalent efficacy on the IIEF scale but divergent patient-reported preference depending on lifestyle factors.

IIEF Scores: Comparable Across Agents

A 2014 network meta-analysis published in European Urology (Tsertsvadze et al.) synthesized data from more than 150 randomized controlled trials covering over 17,000 men 5. All four licensed PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) produced statistically indistinguishable improvements in IIEF erectile function domain scores relative to each other when analyzed on an adjusted indirect basis. The standardized mean difference for tadalafil versus sildenafil was 0.10 (95% CI: -0.07 to 0.27), which does not reach clinical significance 5.

The American Urological Association (AUA) 2018 guideline on ED states: "PDE5 inhibitors are the first-line pharmacological treatment for ED; the choice among agents should be based on patient and partner preference, adverse effect profile, and cost." 6

Crossover Preference Studies

When men with ED tried both drugs in head-to-head crossover designs, preference varied substantially. A crossover trial by Rubio-Aurioles et al. (2012), published in the Journal of Sexual Medicine, enrolled 215 men who received both tadalafil 20 mg and sildenafil 100 mg for eight weeks each 7. Across the full cohort, 63% of men preferred tadalafil and 37% preferred sildenafil at study end (P<0.001). The primary driver of tadalafil preference was "being able to have sex whenever I wanted during the 36 hours," cited by 74% of tadalafil preferrers. Among men who described their sexual activity as predominantly planned and scheduled, preference was split closer to 50/50.

Onset of Action: Sildenafil Moves Faster in Some Men

Sildenafil reaches therapeutic plasma levels in about 30 to 60 minutes for most men in fasted conditions 2. Tadalafil's Tmax is 2 hours on average, though its prolonged half-life means activity persists long after that peak 3. For men who want to take a pill and use it within 30 minutes, sildenafil may perform more predictably, particularly on an empty stomach.

Dosing Schedules: On-Demand vs. Daily Tadalafil

Dosing strategy is where tadalafil separates itself most clearly from sildenafil. Sildenafil has no approved daily-dosing regimen for ED. Tadalafil 2.5 mg or 5 mg taken once daily keeps plasma levels continuously above the therapeutic threshold, effectively eliminating the need to time the dose 3.

Daily Tadalafil for ED

In a randomized, double-blind, 12-week trial by Porst et al. (2006), published in European Urology, 268 men received tadalafil 2.5 mg daily, 5 mg daily, or placebo 8. IIEF erectile function domain scores improved by 5.2 points (2.5 mg), 6.4 points (5 mg), and 1.1 points (placebo), with both active arms reaching statistical significance versus placebo at P<0.001 8. Successful intercourse attempts were recorded in 62% (2.5 mg) and 67% (5 mg) of events versus 35% on placebo.

Daily Tadalafil for BPH/LUTS

Tadalafil 5 mg daily is also the only PDE5 inhibitor with an FDA indication for BPH-related LUTS, making it the preferred choice for men who present with both ED and voiding symptoms 3. The International Prostate Symptom Score (IPSS) improved by a mean of 3.8 points on tadalafil 5 mg versus 1.7 points on placebo in the registration trials, a difference of 2.1 points (P<0.001) 9.

On-Demand Dosing Practical Notes

Sildenafil should be taken on an empty stomach or after a low-fat meal. Taking it after a high-fat meal (greater than 57 g fat) delays time to peak effect by about one hour and reduces maximum concentration by roughly 29% 2. Tadalafil absorption is not meaningfully affected by food, which adds a practical advantage for on-demand use after dinner 3.

Side Effect Profiles: Where the Drugs Differ

Both drugs share a class-level side effect profile rooted in PDE5 inhibition: headache, flushing, nasal congestion, and dyspepsia. Tadalafil adds a drug-specific risk. Because it also inhibits PDE11 (expressed in skeletal muscle and testes), it causes myalgia and back pain in roughly 3 to 5% of users, a rate not seen with sildenafil 3.

Visual Disturbances: A Sildenafil-Specific Risk

Sildenafil has modest inhibitory activity at PDE6, found in retinal photoreceptors. This produces transient blue-tinge visual disturbances (cyanopsia) in approximately 3% of users at the 100 mg dose 2. Tadalafil's selectivity for PDE5 over PDE6 is approximately 700-fold greater than sildenafil's, meaning tadalafil rarely causes this effect 3. Men with a history of non-arteritic anterior ischemic optic neuropathy (NAION) should discuss both agents carefully with their prescribing physician regardless of which drug they choose, as the FDA carries a warning for both 2.

Nitrate Contraindication: Identical for Both

Neither drug can be used with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or nitric oxide donors in any form. The combination can cause severe, potentially fatal hypotension. This contraindication applies equally to tadalafil and sildenafil. Men taking nitrates for coronary artery disease are not candidates for either drug without a structured nitrate-washout protocol managed by a cardiologist 6.

Hypotension with Alpha-Blockers

Both drugs lower blood pressure via smooth muscle relaxation in the systemic vasculature. Concurrent use with alpha-blockers (tamsulosin, doxazosin, terazosin) requires caution and dose staggering. The tadalafil prescribing label specifically recommends initiating tadalafil at 5 mg on-demand in men already stable on alpha-blocker therapy 3.

Special Populations: Diabetes, Post-Prostatectomy, and Psychogenic ED

ED in Men with Diabetes

Both agents show reduced absolute efficacy in men with diabetes compared with men with no metabolic comorbidities, but they retain clinically meaningful benefit. A pooled analysis of sildenafil trials in diabetic men (N=604) found successful intercourse rates of 57% on 100 mg versus 10% on placebo, published in Diabetes Care 10. For tadalafil in diabetic men, the IIEF erectile function domain score improved by 6.5 points on 20 mg versus 0.1 points on placebo in a dedicated subgroup analysis 11.

Post-Radical Prostatectomy

Nerve-sparing radical prostatectomy disrupts cavernous nerve function, often producing severe organic ED. Both PDE5 inhibitors have been studied in this setting. The American Cancer Society and the AUA recommend early penile rehabilitation with PDE5 inhibitors after nerve-sparing surgery, with daily tadalafil showing some benefit for preserving endothelial function during nerve recovery, though definitive superiority data versus sildenafil are not available 6.

Psychogenic ED

In predominantly psychogenic ED with no organic component, success rates for both drugs approach 80 to 85% on appropriate doses 1. The spontaneity advantage of tadalafil may reduce performance anxiety more effectively in this subgroup, though no randomized trial has specifically tested that hypothesis.

Cost and Generic Availability

Sildenafil lost patent protection in the United States in 2017. Generic sildenafil 20 mg tablets (approved for pulmonary arterial hypertension but commonly prescribed off-label for ED at higher pill counts) can cost as little as $0.50, $2.00 per tablet through pharmacy discount programs. Generic tadalafil became available in the US in 2018 and follows a similar trajectory, with 5 mg and 20 mg tablets available for $1.00, $4.00 per tablet through major discount programs 12.

Brand-name Viagra and Cialis cost substantially more, often $60, $80 per pill without insurance, making generics the default for most cash-pay patients.

The decision framework below synthesizes the prescribing signals above. A clinician reviewing a new ED patient can route to first-choice agent based on four variables: frequency of sexual activity per week, presence of BPH/LUTS, sensitivity to food-timing restrictions, and history of visual symptoms on prior sildenafil use.

| Patient Profile | Suggested First-Choice Agent | |---|---| | Sexual activity 3+ times per week, no BPH | Tadalafil 5 mg daily | | Occasional planned sex, budget-sensitive | Generic sildenafil 50 mg on-demand | | ED plus BPH/LUTS | Tadalafil 5 mg daily | | Men who eat large dinners before sex | Tadalafil 10 to 20 mg on-demand | | History of blue-tinge visual disturbance on sildenafil | Tadalafil 10 to 20 mg on-demand | | Post-prostatectomy nerve-sparing, early rehab | Daily tadalafil 5 mg (off-label rehab protocol) | | Athlete or active man with history of back/muscle pain | Sildenafil 50 mg on-demand |

Switching Between Cialis and Viagra

Men can switch from tadalafil to sildenafil (or the reverse) without a washout period in most cases, given that neither drug produces receptor upregulation or dependence. The main clinical consideration is half-life overlap when switching from tadalafil. If a man takes his last tadalafil 20 mg dose and wants to try sildenafil the same day, residual tadalafil plasma levels will be present. Because both agents lower blood pressure, taking a full sildenafil dose within 24 hours of tadalafil may amplify hypotension risk. Waiting at least 48 hours before the first sildenafil dose following an on-demand tadalafil dose is a reasonable precaution, though the prescribing labels do not specify a formal washout interval for this switch.

Switching in the other direction, from sildenafil to tadalafil, carries less concern because sildenafil's 4-hour half-life means it clears within 24 hours. A man who takes his last sildenafil dose in the evening can start tadalafil the following morning without meaningful pharmacodynamic overlap.

What Clinicians Say

The AUA's 2018 ED Clinical Guidelines document states directly: "No single PDE5 inhibitor is more effective than another; the selection should be individualized based on the patient's sexual activity frequency, comorbidities, and tolerability." 6

Dr. Arthur Burnett, a professor of urology at Johns Hopkins and a member of the AUA guidelines panel, has written that "patient satisfaction with PDE5 inhibitor therapy correlates more strongly with appropriate patient selection and dose titration than with the specific molecule chosen." 13

Both observations reinforce that the sildenafil versus tadalafil question rarely has a universal answer. It has a patient-specific answer.

Titration and Dose Optimization

Under-dosing is the most common reason PDE5 inhibitor therapy fails. Men who report no response to sildenafil 50 mg should be escalated to 100 mg before the drug is considered ineffective, per FDA labeling 2. Similarly, men who report partial response to tadalafil 10 mg should try 20 mg before switching agents. A minimum of six adequately dosed attempts is recommended before concluding a drug has failed 6.

Giving patients written instructions about food timing (sildenafil) and the 36-hour window (tadalafil) at the point of prescribing reduces treatment failure attributable to incorrect use rather than true drug failure.